Matching articles for "Aliskiren/Amlodipine"
In Brief: Another Three-Drug Combination for Hypertension
The FDA has approved aliskiren/amlodipine/hydrochlorothiazide (Amturnide) for treatment of hypertension, with no restrictions except that it should not be used for initial therapy. A combination of the direct…
Med Lett Drugs Ther. 2011 Apr 4; 53(1361):28
The FDA has approved aliskiren/amlodipine/hydrochlorothiazide (Amturnide) for treatment of hypertension, with no restrictions except that it should not be used for initial therapy. A combination of the direct renin inhibitor aliskiren and the calcium channel blocker amlodipine (Tekamlo) was approved earlier for initial treatment. 1 Use of combination tablets is, of course, more convenient than taking the components separately, and as long as all the same doses are available and the cost is no greater, there is no reason not to use them. Aliskiren alone or in combination has not been shown to improve clinical outcomes. 2 Whether it offers any advantage over the angiotensin receptor blockers (ARBs), which are also available in various antihypertensive combinations, remains to be determined. 1. Aliskiren/amlodipine (Tekamlo): another combination tablet for hypertension. Med Lett Drugs Ther 2010; 52:94. 2. Drugs for hypertension. Treat Guidel Med Lett 2009; 7:1. Download U.S. English
Aliskiren/Amlodipine (Tekamlo): Another Combination Tablet for Hypertension
The FDA has approved Tekamlo (Novartis), an oral fixed-dose combination of the direct renin inhibitor aliskiren (Tekturna) and the calcium channel blocker amlodipine ( Norvasc , and others), for treatment of…
Med Lett Drugs Ther. 2010 Nov 29; 52(1352):94-5
The FDA has approved Tekamlo (Novartis), an oral fixed-dose combination of the direct renin inhibitor aliskiren (Tekturna) and the calcium channel blocker amlodipine ( Norvasc , and others), for treatment of hypertension in patients not adequately controlled on monotherapy or already taking both drugs, and as initial therapy in those likely to need multiple drugs to control their blood pressure (BP). Both aliskiren and amlodipine are available in combinations with other antihypertensive agents.
